MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Anti-Ma2 Antibody Paraneoplastic Cerebellar Degeneration Associated with Renal Cell Carcinoma: A Case Report.

    K. Zahra, N. Ahmed, D. Sivakumar, E. Urrea-Mendoza, V. Veerappan (Greenville, USA)

    Objective: To highlight a unique case of Anti-Ma2 antibody paraneoplastic cerebellar degeneration (PCD) associated with renal cell carcinoma (RCC). Background: Paraneoplastic neurologic syndromes are a…
  • 2022 International Congress

    Reversible secondary parkinsonism attributed to metformin-induced lactic acidosis

    G. Bailey, V. Salinas, R. Dewey, M. Salinas, L. Tardo (Dallas, USA)

    Objective: We describe the case of a 59-year-old man who was evaluated for abnormal imaging and subacute parkinsonism. Background: Secondary parkinsonism can be caused by…
  • 2022 International Congress

    Characterization of Perioperative Seizures in Patients Undergoing Deep Brain Stimulation for Movement Disorders: A Single-Center Study

    G. Tamula, M. Moya-Mendez, C. O'Donovan, J. Tate, A. Laxton, S. Tatter, M. Siddiqui (WINSTON SALEM, USA)

    Objective: To characterize perioperative seizures in movement disorder patients undergoing deep brain stimulation (DBS) and their outcome. Background: Although seizure is a rare complication of…
  • 2022 International Congress

    CLINICAL CORRELATION OF VISUAL LEUKOARAIOSIS SCALES AND VOLUMETRIC ANALYSIS IN PATIENTS WITH ISCHEMIC CEREBRAL VASCULAR EVENT AND PARKINSON’S DISEASE.

    C. Cerda-Contreras (Monterrey, N.L., Mexico)

    Objective: Search for the clinical correlation of the most used leukoaraiosis scales in Parkinson's disease and ischemic stroke. Background: In recent decades, there has been…
  • 2022 International Congress

    Gender Identity and Treatment Response in Patients with Functional Tic-Like Behavior

    S. Kola, D. Larson (Chicago, USA)

    Objective: The aim of this case series is to add to the limited existing reports on the demographics, clinical history, phenomenology, and treatment response of…
  • 2022 International Congress

    Elimination of STN stimulation-induced dyskinesias with ViM DBS

    D. Shah-Zamora, J. Karl, L. Verhagen (Chicago, USA)

    Objective: To describe effects of thalamic deep brain stimulation (DBS) on severe dyskinesias induced by subthalamic nucleus (STN) DBS in a person with Parkinson’s disease…
  • 2022 International Congress

    Impact of the dopamine system on long-term, incident cognitive impairment in Parkinson disease

    D. Weintraub, M. Picillo, H. Cho, C. Caspell-Garcia, C. Coffey, K. Marek, K. Poston, T. Simuni, J. Seibyl, A. Siderowf, A. Singleton, C. Tanner (Philadelphia, USA)

    Objective: To determine the impact of the dopamine system (dopamine transporter [DAT] availability, dopamine-related SNPs, and dopaminergic medication use) on long-term cognitive performance in early…
  • 2022 International Congress

    Botulinum neurotoxin simulation workshop: Impact on resident satisfaction and knowledge

    C. Selvadurai, E. Cournean, N. Prakash, B. Rodrigues (Farmington, USA)

    Objective: To assess resident satisfaction and knowledge after a hands-on Botulinum toxin (BoNT) simulation workshop (SW). Background: Despite having an application for BoNT in almost…
  • 2022 International Congress

    A Patient-Centered Outcomes Survey in Parkinson’s Disease: Results of Cognitive Pre-Testing

    D. Shah-Zamora, J. Karl, M. Tosin, G. Pal, G. Stebbins, C. Goetz, L. Verhagen (Chicago, USA)

    Objective: To validate the Rush Parkinson's Disease Patient-Centered Outcomes Questionnaire (RUSH-PCO-Q). Background: The RUSH-PCO-Q aims to address the lack of patient-centered outcomes in the field…
  • 2022 International Congress

    Robust methods for missing covariates in longitudinal studies with application to biomarker research in Parkinson’s disease dementia

    L. Suttner, P. Zhang, S. Xie (Philadelphia, USA)

    Objective: We propose a nonparametric method for handling different types of missing covariates in longitudinal studies. We show that the proposed method outperforms multiple standard…
  • « Previous Page
  • 1
  • …
  • 591
  • 592
  • 593
  • 594
  • 595
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley